- Home
- OTLK vs HFBL Comparison
OTLK vs HFBL Comparison
Compare OTLK & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- HFBL
- Stock Information
- Founded
- OTLK 2010
- HFBL 1924
- Country
- OTLK United States
- HFBL United States
- Employees
- OTLK N/A
- HFBL N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- HFBL Savings Institutions
- Sector
- OTLK Health Care
- HFBL Finance
- Exchange
- OTLK Nasdaq
- HFBL Nasdaq
- Market Cap
- OTLK 48.3M
- HFBL 41.3M
- IPO Year
- OTLK 2016
- HFBL N/A
- Fundamental
- Price
- OTLK $0.93
- HFBL $13.50
- Analyst Decision
- OTLK Buy
- HFBL
- Analyst Count
- OTLK 5
- HFBL 0
- Target Price
- OTLK $8.50
- HFBL N/A
- AVG Volume (30 Days)
- OTLK 7.8M
- HFBL 1.4K
- Earning Date
- OTLK 08-14-2025
- HFBL 10-28-2025
- Dividend Yield
- OTLK N/A
- HFBL 3.85%
- EPS Growth
- OTLK N/A
- HFBL 6.78
- EPS
- OTLK N/A
- HFBL 1.26
- Revenue
- OTLK $1,505,322.00
- HFBL $20,802,000.00
- Revenue This Year
- OTLK N/A
- HFBL N/A
- Revenue Next Year
- OTLK $484.88
- HFBL N/A
- P/E Ratio
- OTLK N/A
- HFBL $10.71
- Revenue Growth
- OTLK N/A
- HFBL 1.50
- 52 Week Low
- OTLK $0.79
- HFBL $11.75
- 52 Week High
- OTLK $8.32
- HFBL $14.25
- Technical
- Relative Strength Index (RSI)
- OTLK 31.89
- HFBL 52.82
- Support Level
- OTLK $0.82
- HFBL $13.34
- Resistance Level
- OTLK $0.98
- HFBL $13.44
- Average True Range (ATR)
- OTLK 0.27
- HFBL 0.15
- MACD
- OTLK -0.15
- HFBL 0.04
- Stochastic Oscillator
- OTLK 5.25
- HFBL 73.53
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.